Clinical Trial Update: High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating high-dose chemotherapy followed by stem cell transplantation in patients with newly diagnosed stage I–I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Snippet

Sponsor: Erasme University Hospital | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: UNKNOWN